4//SEC Filing
Rojkjaer Lisa 4
Accession 0000905148-25-000302
CIK 0001034842other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:47 PM ET
Size
7.0 KB
Accession
0000905148-25-000302
Insider Transaction Report
Form 4
Rojkjaer Lisa
EVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-01-29+14,788→ 14,788 totalExercise: $22.49Exp: 2035-01-29→ Common Stock (14,788 underlying) - Award
Common Stock
2025-01-29+19,717→ 19,717 total
Footnotes (2)
- [F1]The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 10, 2025, with the first annual vest occurring on February 10, 2026.
- [F2]The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 29, 2025, subject to the Reporting Person's continuous service to the Issuer through each such period.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001846460
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 6:47 PM ET
- Size
- 7.0 KB